Showing results (1701-1710 of 2,784) with videos related to
Sort By:
Pageof 279
Biomaterials|May 24, 2006
Monitoring cell adhesion on tantalum and oxidised polystyrene using a quartz crystal microbalance with dissipationMegan Susan Lord, Charlotte Modin, Morten Foss, et al.Kidney International|June 18, 2004
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survivalSolbjørg Sagedal, Anders Hartmann, Knut P Nordal, et al.Chemistry and Physics of Lipids|March 24, 2005
Hydrophilic carotenoids: surface properties and aggregation behavior of a highly unsaturated carotenoid lysophospholipidBente Jeanette Foss, Hans-Richard Sliwka, Vassilia Partali, et al.Lipids in Health and Disease|December 6, 2021
Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept studyMaria C Foss-Freitas, Baris Akinci, Adam Neidert, et al.Acta Orthopaedica|September 2, 2014
1-year follow-up of 920 hip and knee arthroplasty patients after implementing fast-trackSiri B Winther, Olav A Foss, Tina S Wik, et al.The British Journal of Ophthalmology|April 14, 2016
Changes in intraocular pressure in study and fellow eyes in the IVAN trialAlexander J E Foss, Lauren J Scott, Chris A Rogers, et al.The British Journal of Ophthalmology|January 30, 1999
Does raised intraocular pressure begin in utero?A J Foss, A Rauf, A Aihie Sayer, et al.Eye (London, England)|May 16, 2009
Second-eye cataract surgery in elderly women: a cost-utility analysis conducted alongside a randomized controlled trialT H Sach, A J E Foss, R M Gregson, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 2003
Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative studySolbjørg Sagedal, Knut P Nordal, Anders Hartmann, et al.Scandinavian Journal of Gastroenterology|August 28, 2003
Tumour necrosis factor alpha and its promoter polymorphisms' role in the phenotypic expression of hemochromatosisS Distante, M Elmberg, K B Foss Haug, et al.Pageof 279